2010 Annual Sunday

Chicago, IL - 2010 ASCO Annual Meeting: Robert A. Burger, MD, addresses the "Other Cancers: GI/GU/GYN Press Conference" about Abstract "Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC) or Fallopian tube cancer (FTC): A Gynecologic Oncology Group study" at the American Society of Clinical Oncology Annual Meeting on Sunday, June 6, 2010. Over 32,000 physicians, researchers and healthcare professionals from over 100 countries attended the meeting, which was held at McCormick Place and featured the latest innovations in cancer research, quality, practice, and technology. Date: Sunday June 6, 2010 Photo by © ASCO/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org